Analyst Activity – Bryan, Garnier & Co Reiterates Buy on GlaxoSmithKline plc (LON:GSK)

ME Staff
-
0

Analyst Ratings For GlaxoSmithKline plc (LON:GSK)

Today, Bryan, Garnier & Co reiterated its Buy rating on GlaxoSmithKline plc (LON:GSK) with a price target of GBX 1,750.

There are 4 sell ratings, 11 hold ratings, 8 buy ratings on the stock.

The current consensus rating on GlaxoSmithKline plc (LON:GSK) is Hold (Score: 2.17) with a consensus target price of GBX 1,738.82 per share, a potential .

Some recent analyst ratings include

  • 7/20/2017-Bryan, Garnier & Co Reiterated Rating of Buy.
  • 7/20/2017-Shore Capital Reiterated Rating of Hold.
  • 7/20/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Buy.
  • 7/19/2017-Deutsche Bank AG Reiterated Rating of Hold.
  • 7/18/2017-Morgan Stanley Reiterated Rating of Equal weight.
  • 7/13/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
  • 7/13/2017-Jefferies Group LLC Reiterated Rating of Buy.


    Recent Trading Activity for GlaxoSmithKline plc (LON:GSK)
    Shares of GlaxoSmithKline plc closed the previous trading session at 1,625.43 up +14.93 0.93% with 5,755,230 shares trading hands.